TickerFacts.

Company research / IDXX

IDEXX LABORATORIES INC /DE (IDXX)

Build a valuation ↗↓ Download CSV

CIK 0000874716 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, IDEXX LABORATORIES INC /DE reported revenue of $4.30B. Revenue grew 10.4% from the prior annual period.

Key ratios (year ended 2025-12-31)

61.8%
Gross margin
31.6%
Operating margin
24.6%
Net margin
66.0%
Return on year-end equity
10.4%
Revenue growth (YoY)

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312019-01-012018-12-312018-01-01
Revenue$4.30B$3.90B$3.66B$3.37B$3.22B$2.71B$2.41B—$2.21B—
Cost of Revenue$1.64B$1.52B$1.47B$1.36B——————
Gross Profit$2.66B$2.38B$2.19B$2.00B$1.89B$1.57B$1.37B—$1.24B—
Operating Income$1.36B$1.13B$1.10B$898.76M$932.03M$694.52M$552.85M—$491.33M—
Net Income$1.06B$887.87M$845.04M$679.09M$744.85M$581.78M$427.72M—$377.03M—
EPS (Diluted)$13.08$10.67$10.06$8.03$8.60$6.71$4.89—$4.26—
Total Assets$3.35B$3.29B$3.26B$2.75B$2.44B$2.29B$1.83B$1.62B$1.54B$1.74B
Total Liabilities$1.75B$1.70B$1.78B$2.14B$1.75B$1.66B$1.65B$1.63B$1.55B$1.80B
Shareholders' Equity$1.61B$1.60B$1.48B$608.74M$689.99M$632.09M$177.47M—-$9.51M—
Cash & Equivalents$180.07M$288.27M$453.93M$112.55M$144.45M$383.93M$90.33M—$123.79M—
Operating Cash Flow$1.18B$929.00M$906.51M$542.98M$755.55M$648.06M$459.16M—$400.08M—
Capital Expenditures$124.68M$120.92M$133.63M$148.84M$119.55M$106.96M$154.97M—$115.75M—
Shares Outstanding79.71M81.60M83.03M82.89M84.56M85.45M85.47M—86.10M—
Weighted Average Diluted Shares81.03M83.25M83.98M84.60M86.57M86.72M87.54M—88.47M—
EPS (Basic)$13.17$10.77$10.17$8.12$8.74$6.82$4.97—$4.34—